1 |
Hanawa T, Endoh N, Suzuki M, Terada K, Ohkuma M, Sakuta K, et al. Release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing used for intravenous administration and the plasticized PVC membrane. Internat J Pharm. 2005;297:30-7.
DOI
|
2 |
Demore' B, Vigneron J, Perrin A, Hoffman MA, Hoffman M. Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous etoposide solution. J Clinical Pharm Therap. 2002;27:139-42.
DOI
|
3 |
Joel AT, Ted S, Tee G, Michael MC, Mark R. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: A critical review. Am J Ind Med. 2001;39:100-11.
DOI
|
4 |
Koch HM, Preuss R, Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int J Androl. 2006;29:155-65.
DOI
|
5 |
Anna T, Gerd W, Rainer B, Frank W. Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application. Int J Pharm. 2009;369:30-7.
DOI
|
6 |
Takehisa H, Emi M, Kohki A, Masahiko S, Mutsuko T, Kenji K, et al. Investigation of the release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing for intravenous administration. Int J Pharm. 2000;210:109-15.
DOI
|
7 |
Kalra N, Nagpal M, Nyola NK. Sensitive high-performance liquid chromatographic method for the determination of taxol category drug in plasma. Int J Pharm Sci. 2013;2(3-4):65-8.
|
8 |
Yuji H, Fumie S, Tae H, Haruko Y, Chile H, Shunichiro I, et al. Development of a simple method for predicting the levels of di(2-ethylhexyl) phthalate migrated from PVC medical devices into pharmaceutical solutions. Int J Pharm. 2005;298:126-42.
DOI
|
9 |
Park KH, Park CK, Park J, Jeon SH, Bang SI, Kim JH, et al. Drug adsorption behavior of Polyolefin infusion tube compared to PVC and PU. Polymer (Korea). 2014;38(3):333-7.
DOI
|